Legal Opinion
Ben Venue Laboratories, Inc. v. Novartis Pharmaceutical Corp.
District Court, D. New Jersey
Decided May 30, 2001No. CIV 99-2006 WGBPublishedCited by 8 opinions
1Opinion of the Court
OPINION and ORDER
BASSLER, District Judge:
This matter arises out of Ben Venue Laboratories’ quest to produce a generic version of the patented bone drug Aredia (R), in the face of vehement opposition by the patent holder, Novartis Pharmaceutical Corporation. The procedural history of this dispute is complex, and every issue that has come before the Court has been hard fought by the litigants. At an oral argument on February 14, 2000 it was brought to the Court’s attention that it might lack subject matter jurisdiction over a particular segment of the litigation. The Court subsequently invited…
2Cases cited7 opinions
- Eli Lilly & Co. v. Medtronic, Inc.Supreme Court of the United States · 1990
- Bayer Ag and Bayer Corporation v. Elan Pharmaceutical Research Corporation and Elan Corporation, PlcCourt of Appeals for the Federal Circuit · 2000
- Glaxo, Inc., and Glaxo Group Limited v. Novopharm, Ltd.Court of Appeals for the Federal Circuit · 1997
- Biovail Corporation International, Biovail Laboratories,inc., and Galephar P.R., Inc. Ltd. v. Andrx Pharmaceuticals, Inc.Court of Appeals for the Federal Circuit · 2001
- Bristol-Myers Squibb Company and E.R. Squibb & Sons, Inc. v. Royce Laboratories, Inc.Court of Appeals for the Federal Circuit · 1995
2 more not listed; retrieve them via the Exa API.
3Cited by8 opinions
- Novartis Corporation v. Ben Venue Laboratories, Inc., and Bedford LaboratoriesCourt of Appeals for the Federal Circuit · 2001
- Dr. Reddy's Laboratories, Inc. v. ThompsonDistrict Court, D. New Jersey · 2003
- Abraxis Bioscience, Inc. v. NAVINTA, LLCDistrict Court, D. New Jersey · 2009
- Pfizer Inc. v. Teva Pharmaceuticals U.S.A., Inc.District Court, D. Delaware · 2012
- Sanofi-Aventis v. BARR LABORATORIES, INC.District Court, D. New Jersey · 2009
3 more not listed; retrieve them via the Exa API.